NCT07517458

Brief Summary

The study stems from the need to have available effective tools for detecting the anxiety of the cancer patient who has to undergo surgery. The period leading up to surgery, is characterized by strong emotions that create an upheaval in the work, family and social life of the patient as well as concern about the unknown. It would be crucial to ensure a personalized nursing care by having scales of assessment specific to the clinical-surgical oncology setting in order to collect the patient's emotions, concerns and fears. Despite the numerous scales available, many of them have limitations concerning the issues they go to investigate but also concerning the timeframes for compilation, which are often long and laborious so they are difficult to apply. The study aims to validate in the Italian context the Surgical Anxiety Questionnaire (SAQ) questionnaire, already translated and validated in multiple languages, to detect which factors are the most influential in increasing preoperative anxiety, with the aim of implementing education of the patient and implement strategies and interventions that can reduce anxiety.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P50-P75 for all trials

Timeline
6mo left

Started May 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
May 2024Dec 2026

Study Start

First participant enrolled

May 23, 2024

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

March 20, 2026

Completed
12 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 8, 2026

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

April 8, 2026

Status Verified

April 1, 2026

Enrollment Period

1.9 years

First QC Date

March 20, 2026

Last Update Submit

April 1, 2026

Conditions

Outcome Measures

Primary Outcomes (5)

  • To assess the content validity of the SAQ translation

    The content validity will be assessed by a panel of 5 experts and rated on a Content Validity Index (CVI). A CVI score \>=0.78 will indicate excellent content validity

    up to 1 year

  • To assess criterion validity of the SAQ translation

    Criterion validity will be assessed by calculating the correlation between the translated SAQ total score and a validated Hamilton Rating for Anxiety (HAM-A)

    up to 1 year

  • To assess the reliability of the SAQ translation

    Internal consistency will be measured with Cronbach alpha

    up to 1 year

  • To assess the construct validity of the SAQ translation

    Confirmatory Factor Analysis will be carried out to assess construct validity. Factor loadings, eigenvalues and explained variance will be reported

    up to 1 year

  • To assess the construct validity of the SAQ translation

    Exploratory Factor Analysis will be carried out to assess construct validity. Factor loadings, eigenvalues and explained variance will be reported

    up to 1 year

Secondary Outcomes (1)

  • Measuring the level of preoperative anxiety in patients undergoing surgery at the Centro di Oncology Reference Center-IRCCS of Aviano (IRCCSCRO Aviano)

    up to 1 year

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with oncological pathology who will have to undergo surgery at IRCCS-CRO Aviano

You may qualify if:

  • In ordinary hospitalization, day surgery, day hospital
  • Age ≥ 18 years
  • Signature of consent participation in the study and personal data collection and processing
  • Good understanding of the Italian language

You may not qualify if:

  • Age \< 18 years
  • Diagnosis of cognitive dysfunction and psychiatric disorders, or uncooperative patient
  • Difficulty in understanding the Italian language

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS

Aviano, Pordenone, 33081, Italy

RECRUITING

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Central Study Contacts

Cristina Mazzega Fabbro

CONTACT

Lucia Cadorin, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 20, 2026

First Posted

April 8, 2026

Study Start

May 23, 2024

Primary Completion

April 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

April 8, 2026

Record last verified: 2026-04

Locations